Sana Biotechnology Inc
(NAS:SANA)
$
3.39
-0.37 (-9.84%)
Market Cap: 754.16 Mil
Enterprise Value: 678.94 Mil
PE Ratio: 0
PB Ratio: 2.22
GF Score: 36/100 
Sana Biotechnology Inc at Citi BioPharma Conference Transcript
Sep 06, 2023 / 02:30PM GMT
Release Date Price:
$5.92
(+2.07%)
Samantha Lynn Semenkow
Citigroup Inc., Research Division - VP
All right, welcome. Thank you everyone. It's a pleasure here to host Steve Harr, CEO of Sana Biotechnology. Steve, thank you for being with us today.
Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director
(inaudible).
Samantha Lynn Semenkow
Citigroup Inc., Research Division - VP
I want to if both mics working.
Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director
Can you hear me now? There we go.
Questions & Answers
Samantha Lynn Semenkow
Citigroup Inc., Research Division - VP
All right. Great. Well, then maybe you can just start us off for those that are a little bit less familiar with Sana, and just giving maybe a 2-minute high-level overview of the company, what you do, where you're working towards.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers